Interaction of Gal-1 and VEGFR2 leads to prolonged presence of the receptor in the cell membrane of endothelial cells thereby promoting tumor regrowth, which may limit the efficacy of anti-VEGF treatment [4]. Here, VEGFA is linked to neoplasm.